Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06523634 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.

Study acronym: STEREOBED
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 12 to 13v12
  2. Study sites revised (12)v11 See this version in full on ClinicalTrials.gov ↗
  3. Study sites: 11 to 12v10
  4. Study sites: 9 to 11v9
  5. Study sites: 8 to 9v8
Show 6 earlier versionsHide 6 earlier versions
  1. Study sites: 7 to 8v7
  2. Site details revised at 3 of 7 sitesv6
  3. Site details revised at 1 of 7 sitesv5
  4. Study sites: 1 to 7v4
  5. Start date changed from estimate of Dec 1, 2024 to Dec 10, 2024v3
  6. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Dec 1, 2026 to Feb 1, 2029 · Study sites: 0 to 1 · Completion date: Dec 1, 2030 to Feb 1, 2032 · 2 morev2 Show 5 more changesShow less
    • Primary completion date: Dec 1, 2026 to Feb 1, 2029
    • Study sites: 0 to 1
    • Completion date: Dec 1, 2030 to Feb 1, 2032
    • Interventions: SOC RT (Radiation), stereotactic body radiotherapy (Radiation) to SOC RT (Radiation), Stereotactic body radiotherapy (SBRT) (Radiation)
    • Study description shortened, about 6 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a a randomized phase II/III trial comparing salvage SBRT with standard of care (SOC) regimens for patients with a persistent detectable PSA or biochemical progression during follow-up after radical prostatectomy.
Trial Details
NCT Number NCT06523634
Lead Sponsor Jules Bordet Institute
Conditions Prostate Cancer
Enrollment 284 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov